Controlled Study of Atomoxetine in ADHD

Abstract

Researchers at the Department of Psychiatry, University of Nebraska Medical Center, Omaha, and other centers in the US conducted an 8-week, double-blind, placebo-controlled study of atomoxetine for treatment of ADHD in 101 children 5- and 6-years of age and older.

Keywords

• appetite
• gastrointestinal upset
• sedation